TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY

被引：0
|
作者：
Patil, A. [1 ]
Upadhyaya, S. K. [1 ]
Dawar, R. [2 ]
Vaishnav, B. [1 ]
Dadhaniya, N. [1 ]
Gupta, S. J. [1 ]
Handa, R. [1 ]
机构：
[1] Indraprastha Apollo Hosp, Rheumatol, Delhi, India
[2] Indraprastha Apollo Hosp, Microbiol, Delhi, India
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.2690
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0683
引用
收藏
页码：1292 / 1292
页数：1
相关论文
共 50 条
  • [41] Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
    Merras-Salmio, Laura
    Kolho, Kaija-Leena
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (02): : 272 - 278
  • [42] Clinical correlations of infliximab trough levels and antibodies to infliximab in Korean patients with Crohn's disease
    Oh, E. H.
    Ko, D. -H.
    Seo, H.
    Chang, K.
    Kim, G. -U.
    Song, E. M.
    Seo, M.
    Lee, H. -S.
    Hwang, S. W.
    Yang, D. -H.
    Ye, B. D.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Park, S. H.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S283 - S284
  • [43] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [44] Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
    Sorrentino, Dario
    Hauenstein, Scott
    Marino, Marco
    Lockton, Steven
    Zarifi, Dimitra
    Del Bianco, Tiziana
    Singh, Sharat
    GASTROENTEROLOGY, 2013, 144 (05) : S777 - S777
  • [45] Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
    Sorrentino, Dario
    Marino, Marco
    Dassopoulos, Themistocles
    Zarifi, Dimitra
    Del Bianco, Tiziana
    PLOS ONE, 2015, 10 (12):
  • [46] Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study
    Veisman, Ido
    Barzilay, Oranit
    Bruckmayer, Liora
    Haj-Natour, Ola
    Kopylov, Uri
    Eliakim, Rami
    Ben-Horin, Shomron
    Ungar, Bella
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
  • [47] In vitro evaluation of infliximab-specific T cells and correlation with the development of anti-infliximab antibodies in treated patients
    Petroni, G.
    Pratesi, S.
    Nencini, F.
    Maggi, E.
    Matucci, A.
    Vultaggio, A.
    ALLERGY, 2014, 69 : 377 - 377
  • [48] Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease
    Oh, Eun Hye
    Ko, Dae-Hyun
    Seo, Hyungil
    Chang, Kiju
    Kim, Gwang-Un
    Song, Eun Mi
    Seo, Myeongsook
    Lee, Ho-Su
    Hwang, Sung Wook
    Yang, Dong-Hoon
    Ye, Byong Duk
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Park, Sang Hyoung
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (08) : 1489 - 1496
  • [49] A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
    van den Bemt, B. J. F.
    Vos, K.
    den Broeder, A. A.
    Blom, M.
    Thurlings, R. M.
    Bartelds, G. M.
    Stapel, S. O.
    Barrera, P.
    Tak, P. P.
    Nurmohamed, M. T.
    Wolbink, G-J
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (08) : 1368 - 1369
  • [50] Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn's disease
    Eun Hye Oh
    Dae-Hyun Ko
    Hyungil Seo
    Kiju Chang
    Gwang-Un Kim
    Eun Mi Song
    Myeongsook Seo
    Ho-Su Lee
    Sung Wook Hwang
    Dong-Hoon Yang
    Byong Duk Ye
    Jeong-Sik Byeon
    Seung-Jae Myung
    Suk-Kyun Yang
    Sang Hyoung Park
    World Journal of Gastroenterology, 2017, 23 (08) : 1489 - 1496
12345